Efficacy of Buspirone in the Treatment of Posttraumatic Stress Disorder: An Open Trial

REFERENCES

• American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders. 3rd ed. Washington, DC: American Psychiatric Association; 1980
   Google Scholar
• American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders. 3rd ed., rev. Washington, DC: American Psychiatric Association; 1987
   Google Scholar
• Wolfe J, Keane TM: Diagnostic validity of posttraumatic stress disorder. In: Wolf ME, Mosnaim AD, eds. Posttrau-matic Stress Disorder: Etiology, Phenomenology, and Treat-ment. Washington, DC: American Psychiatric Press; 1990:48–63
   Google Scholar
• Helzer J, Robins L, McEvoy L: Post-traumatic stress disorder in the general population. N Engl J Med 1987; 317:1630–1634
   PubMed Web of Science ®Google Scholar
• Pitman RK, Altman B, Macklin ML: Prevalence of posttrau-matic stress disorder in wounded Vietnam veterans. Am J Psychiatry 1989; 146:667–669
   PubMed Web of Science ®Google Scholar
• Sierles FS, Chen J, McFarland RE, et al.: Posttraumatic stress disorder and concurrent psychiatric illness: preliminary re-port. Am J Psychiatry 1983; 140:1177–1179
   Google Scholar
• Blake DJ: Treatment of acute posttraumatic stress disorder with tricyclic antidepressants. South Med J 1986; 79:201–204
   Web of Science ®Google Scholar
• Bleich A, Seigel B, Garb R, et al.: Post-traumatic stress dis-order following combat exposure: clinical features and psy-chopharmacological treatment. Br J Psychiatry 1986; 149:365–369
   Google Scholar
• Kauffman CD, Reist C, Djenderedjian A, el al.: Biological markers of affective disorders and post traumatic stress dis-order: a pilot study with desipramine. J Clin Psychiatry 1987; 48:366–367
   Google Scholar
• Davidson J, Walker JL, Kilts C: A pilot study of phenelzine in the treatment of post-traumatic stress disorder. Br „I Psy-chiatry 1987; 150:252–255
   Google Scholar
• Davidson J, Kudler H, Smith R: Treatment of post traumatic stress disorder with amitryptiline and placebo. Arch Gen Psy-chiatry 1990; 47:259–266
   PubMed Web of Science ®Google Scholar
• Reist C, Kauffman CD, Haier RJ, et al.: A controlled trial of desipramine in 18 men with posttraumatic stress disorder. Am J Psychiatry 1989; 146: 513–520
   Google Scholar
• Frank JB, Kosten TR, Giller EL, et al.: A randomized clinical trial of phenelzine and imipramine for post traumatic stress disorder. Am J Psychiatry 1988; 1145:289–129
   Google Scholar
• Friedman MJ: Interrelationships between biological mecha-nisms and pharmacotherapy of posttraumatic stress disorder. In: Wolf ME, Mosnaim AD, eds. Posttraumatic Stress Dis-order: Etiology, Phenomenology, and Treatment. Washing-ton, DC: American Psychiatric Press; 1990:205–225
   Google Scholar
• March JS: Fluoxetine and Fluvoxamine in PTSD (letter). Am J Psychiatry 1992; 149:3,413
   PubMedGoogle Scholar
• Fesler FA: Valproate in combat related posttraumatic stress disorder. J Clin Psychiatry 1991; 52:361–364
   PubMed Web of Science ®Google Scholar
• Nagy LM, Morgan CA, Southwick SM, Charney DS: Open prospective trial of fluoxetine for posttraumatic stress disor-der. J Clin Psychopharmacol 1993; 13:107–113
   PubMed Web of Science ®Google Scholar
• Duffy JD. Rapid efficacy of buspirone in a case of PTSD. Ann Clin Psychiatry 1992; 4:193–196
   Google Scholar
• LaPorta LD, Ware MR: Buspirone in the treatment of post-traumatic stress disorder (letter). J Clin Psychopharmacol 1992; 12:133–134
   PubMed Web of Science ®Google Scholar
• Simpson MA: Buspirone, benzodiazepines, and post-trau-matic stress disorder. J Traum Stress 1991; 7:118–119
   Google Scholar
• Davidson JRT: Assessment and pharmacotherapy of posttrau-matic stress disorder. In: Giller EL, ed. Biological Assess-ment and Treatment of Posttraumatic Stress Disorder. Washington, DC: American Psychiatric Press; 1990:203–234
   Google Scholar
• Beck AT, Ward CH, Mendelson M, et al.: An inventory for measuring depression. Arch Gen Psychiatry 1961; 4:561–571
   PubMed Web of Science ®Google Scholar
• Horowitz M, Wilner N, Alvarez N: Impact of Events Scale: a measure of subjective distress. Psychosom Med 1979; 41;209–218
   PubMed Web of Science ®Google Scholar
• Riekels K, Schweizer E, Csanalosi I, Case WG, Chung H: Long term treatment of anxiety and risk of withdrawal. Pro-spective comparison of clorazepate and busirone. Arch Gen Psychiatry 1988; 45:444–450
   Google Scholar
• Robinson DS, Alms DR, Shrotiya RC, Messina M, Wick-ramatane P: Serotinergic anxiolytics and the treatment of de-pression. Psychopathology 1989; 22\(suppl 1):27–36
   Google Scholar
• 'crystal JH: Animal models for posttraumatic stress disorder. In: Giller EL, ed. Biological Assessment and Treatment of Posttraumatic Stress Disorder. Washington, DC: American Psychiatric Press; 1990:3–26
   Google Scholar
• Giral P, Martin P, Soubrie P, et al: Reversal of helpless be-havior in rats by putative 5-HT1A agonists. Biol Psychiatry 1988; 23:237–242
   PubMedGoogle Scholar